Journal
NATURE REVIEWS MICROBIOLOGY
Volume 4, Issue 11, Pages 865-873Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrmicro1532
Keywords
-
Categories
Funding
- NIAID NIH HHS [U19 AI067854, U19 AI067854-03] Funding Source: Medline
Ask authors/readers for more resources
Genomics is now a core element in the effort to develop a vaccine against HIV-1. Thanks to unprecedented progress in high-throughput genotyping and sequencing, in knowledge about genetic variation in humans, and in evolutionary genomics, it is finally possible to systematically search the genome for common genetic variants that influence the human response to HIV-1. The identification of such variants would help to determine which aspects of the response to the virus are the most promising targets for intervention. However, a key obstacle to progress remains the scarcity of appropriate human cohorts available for genomic research.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available